Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses
- PMID: 17709158
- PMCID: PMC7115420
- DOI: 10.1016/j.vaccine.2007.06.047
Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses
Abstract
Cellular immune response plays an important role in antiviral immunity. In our previous study, immunization of mice with severe acute respiratory syndrome coronavirus (SARS CoV) spike (S) DNA vaccine could induce both humoral and cellular immunity in response to a pool of entire overlapping S peptides. Identification of functional dominant epitopes in SARS CoV S protein for T cells is crucial for further understanding of cellular immune responses elicited by SARS CoV S DNA vaccine. In present study, mice were immunized with SARS CoV S DNA vaccine. Subsequently, a pool of 17-19 mers overlapped SARS CoV S peptides, which served as immunogens, were scanned to identify the specific epitopes for T cells. Two H-2(d) restricted CD4(+) T epitopes, N60 (S435-444) and P152 (S1111-1127), and two H-2(d) restricted CD8(+) T cell epitopes, N50 (S365-374) and P141 (S1031-1047) were identified by three different methods, enzyme-linked immunosorbent assay (ELISA), enzyme linked immunospot assay (ELISPOT) and fluorescence activated cell sorter (FACS). The dominant CD4(+) T cell epitope (N60) and CD8(+) T cell epitope (N50) located in the receptor-binding domain (RBD) of SARS CoV S protein, which mediated virus combining and fusing to susceptible cells. Importantly, our novel finding is that mice primed with SARS S DNA vaccine and boosted with T cell epitopes (N50 and N60) could promote antigen specific CD4(+) and CD8(+) T cell immune responses. Our study provides valuable information for the design of vaccine for SARS study.
Figures







Similar articles
-
Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.Virology. 2005 Apr 25;335(1):34-45. doi: 10.1016/j.virol.2005.01.050. Virology. 2005. PMID: 15823604 Free PMC article.
-
CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein.Vaccine. 2010 Sep 24;28(41):6666-74. doi: 10.1016/j.vaccine.2010.08.013. Epub 2010 Aug 13. Vaccine. 2010. PMID: 20709007 Free PMC article.
-
Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses.Vaccine. 2006 Jun 5;24(23):4905-13. doi: 10.1016/j.vaccine.2006.03.058. Epub 2006 Apr 4. Vaccine. 2006. PMID: 16621188 Free PMC article.
-
Vaccine design for severe acute respiratory syndrome coronavirus.Viral Immunol. 2005;18(2):327-32. doi: 10.1089/vim.2005.18.327. Viral Immunol. 2005. PMID: 16035944 Review.
-
SARS Immunity and Vaccination.Cell Mol Immunol. 2004 Jun;1(3):193-8. Cell Mol Immunol. 2004. PMID: 16219167 Review.
Cited by
-
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.Front Immunol. 2020 Aug 7;11:1949. doi: 10.3389/fimmu.2020.01949. eCollection 2020. Front Immunol. 2020. PMID: 32849654 Free PMC article. Review.
-
Immune responses during COVID-19 infection.Oncoimmunology. 2020 Aug 25;9(1):1807836. doi: 10.1080/2162402X.2020.1807836. Oncoimmunology. 2020. PMID: 32939324 Free PMC article. Review.
-
Betacoronavirus Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic.Int J Mol Sci. 2020 Jun 26;21(12):4546. doi: 10.3390/ijms21124546. Int J Mol Sci. 2020. PMID: 32604724 Free PMC article. Review.
-
Longitudinal determination of BNT162b2 vaccine induced strongly binding SARS-CoV-2 IgG antibodies in a cohort of Romanian healthcare workers.Vaccine. 2022 Sep 2;40(37):5445-5451. doi: 10.1016/j.vaccine.2022.07.040. Epub 2022 Aug 1. Vaccine. 2022. PMID: 35931634 Free PMC article.
-
Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV.BMC Immunol. 2009 Dec 3;10:61. doi: 10.1186/1471-2172-10-61. BMC Immunol. 2009. PMID: 19958537 Free PMC article.
References
-
- Drosten C., Gunther S., Preiser W., van der Werf S., Brodt H.R., Becker S. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348(20):1967–1976. - PubMed
-
- WHO. Severe acute respiratory syndrome (SARS). http://www.who.int/csr/sars/en/ last updated 2 July 2004.
-
- Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 2003;300(5624):1394–1399. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous